The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) EBIT : BDT Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry EBIT?

The IBN SINA Pharmaceutical Industry's earnings before interest and taxes (EBIT) for the six months ended in . 20 was BDT0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

The IBN SINA Pharmaceutical Industry EBIT Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry EBIT Chart

The IBN SINA Pharmaceutical Industry Annual Data

Trend

EBIT

The IBN SINA Pharmaceutical Industry Semi-Annual Data

EBIT

Competitive Comparison of The IBN SINA Pharmaceutical Industry's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The IBN SINA Pharmaceutical Industry's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's EV-to-EBIT falls into.

The IBN SINA Pharmaceutical Industry EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was BDT Mil.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The IBN SINA Pharmaceutical Industry's annualized ROC % for the quarter that ended in . 20 is calculated as:

	ROC % (Q: . 20 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: . 20 )	+	Invested Capital (Q: . 20 ))	/ count )
=	* ( 1 - % )	/	( (	+	)	/ )
=		/
=	%

where

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

The IBN SINA Pharmaceutical Industry's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

	ROC (Joel Greenblatt) %		(Q: . 20 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: . 20		Q: . 20
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=		/	( ( ( + max(, 0))	+	( + max(, 0)) )	/	)
=		/	( (	+	)	/	)
=		/
=	%

where Working Capital is:

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The IBN SINA Pharmaceutical Industry's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: . 20 )
	=		/	0.000
	=	%

The IBN SINA Pharmaceutical Industry EBIT Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207

Website

https://www.ibnsinapharma.com

The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Headlines

No Headlines